Looking for growth shares to buy? Well, here’s some good news! Listed below are two growth shares that have recently been named as buys with material upside potential.
Here’s what you need to know about them:
Altium Limited (ASX: ALU)
The first ASX growth share to look at is Altium. It is an electronic design software provider behind the Altium 365 and Altium Designer platforms.
Altium also has a number of complementary businesses such as Nexus and Octopart which have large opportunities and are generating significant revenues.
All in all, this means Altium has a portfolio of businesses that have positioned it perfectly to profit from the increasing demand for electronic design software due to the rapidly growing Internet of Things (IoT) and AI markets.
Bell Potter is a fan of Altium and was pleased with its “strong” half year results last month. It currently has a buy rating and $38.75 price target on the company’s shares.
Pro Medicus Limited (ASX: PME)
Another ASX growth share that is highly rated is Pro Medicus. It provides industry-leading software that facilitates the clinical assessment of medical images.
The team at Morgans is positive on the company and was very impressed with its recent half year update. This was particularly the case with its margins, which surprised to the upside.
It commented: “While revenues were in-line with our forecasts, EBIT margins (~65%) was really the standout, with a 600bp improvement versus our expectation of a 100bps decline on the pcp, where we assumed the resumption of major marketing conferences and travel expenses would curb margin growth. We were wrong.”
Morgans also notes that the company’s sales pipeline continues to strengthen, which bodes well for its future growth and is expected to underpin further operating leverage over the long term.
In light of this positive outlook, it recently retained its add rating and lifted its price target on the company’s shares to $56.20.
The post 2 high quality ASX growth shares analysts believe have 20%+ upside appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- Altium (ASX:ALU) share price hinges on this key detail, top brokers say
- Glitch! Why are ASX tech shares getting hammered on Monday?
- Why we just sold Zip and bought Pro Medicus (ASX:PME) shares: fundie
- 3 buy-rated ASX growth shares analysts are recommending
- 2 ASX healthcare shares analysts rate as buys
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Altium and Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/VUmeMip
Leave a Reply